The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Retinal Microvascular and Neurodegenerative Changes in Alzheimer’s Disease and Mild Cognitive Impairment Compared with Control Participants
Open accessAbstract
Purpose: To evaluate and compare the retinal microvasculature in the superficial capillary plexus (SCP) in persons with Alzheimer’s disease (AD), mild cognitive impairment (MCI), and cognitively intact controls using optical coherence tomography angiography (OCTA). Various OCT parameters were also compared. Design: Cross-sectional study. Participants: 70 eyes from 39 AD subjects, 72 eyes from 37 MCI subjects, and 254 eyes from 133 control subjects were enrolled. Methods: Subjects were imaged using the Zeiss Cirrus HD-5000 with AngioPlex. All subjects underwent cognitive evaluation with Mini Mental State Examination (MMSE). Main Outcome Measures: The vessel density (VD) and perfusion density (PD) in the SCP within the Early Treatment Diabetic Retinopathy Study (ETDRS) 6mm circle, 3mm circle, and 3mm ring were compared between groups. The foveal avascular zone (FAZ) area, central subfield thickness (CST), macular ganglion cell-inner plexiform layer (GC-IPL) thickness, and peripapillary retinal nerve fiber layer (RNFL) thickness were also compared. Results: AD subjects had a significantly decreased SCP VD and PD in the 3mm ring (p=0.001 and 0.002 respectively) and 3mm circle (p=0.003 and 0.004 respectively) as well as VD in the 6mm circle (p=0.047) when compared to MCI and a significantly decreased SCP VD and PD in the 3mm ring (p=0.008 and 0.004 respectively) and 3mm circle (p=0.015 and 0.009 respectively) as well as PD in the 6mm circle (p=0.033) when compared to cognitively intact controls. However, there was no difference in SCP VD or PD between MCI and controls (p>0.05). The FAZ area and CST did not significantly differ between groups (p>0.05). AD subjects had significantly decreased GC-IPL thickness over the inferior (p=0.032) and inferonasal (p=0.025) sectors compared to MCI subjects and significantly decreased GC-IPL thickness over the whole (p=0.012), superonasal (p=0.041), inferior (p=0.004), and inferonasal (p=0.006) sectors when compared to controls. MCI subjects had significantly decreased temporal RNFL thickness (p=0.04) compared to controls. Conclusions: AD subjects had significantly reduced macular VD, PD, and GC-IPL thickness compared to MCI and control subjects. Changes in the retinal microvasculature may mirror small vessel cerebrovascular changes in AD. These parameters may serve as surrogate non-invasive biomarkers in the diagnosis of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642
Review: Cerebral microvascular pathology in ageing and neurodegeneration
Brown, W. R., & Thore, C. R. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01139.x · Cited by 749
Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., Schwartz, M., & Farkas, D. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.020 · Cited by 672
Ward, A., Tardiff, S., Dye, C., & Arrighi, H. M. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000354370 · Cited by 426
β-Amyloid, Blood Vessels, and Brain Function
Smith, E. E., & Greenberg, S. M. (2009) · Stroke · doi:10.1161/strokeaha.108.536839 · Cited by 293
Cited by
ROSE: A Retinal OCT-Angiography Vessel Segmentation Dataset and New Model
Ma, Y., Hao, H., Xie, J., Fu, H., Zhang, J., Yang, J., Wang, Z., Liu, J., Zheng, Y., & Zhao, Y. (2021) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2020.3042802 · Cited by 310
Alber, J., Goldfarb, D., Thompson, L. I., Arthur, E., Hernandez, K., Cheng, D., DeBuc, D. C., Cordeiro, F., Provetti‐Cunha, L., den Haan, J., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12006 · Cited by 154
Evaluating the neuroprotective impact of senolytic drugs on human vision
El-Nimri, N. W., Moore, S. M., Zangwill, L. M., Proudfoot, J. A., Weinreb, R. N., Skowronska-Krawczyk, D., & Baxter, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-78802-4 · Cited by 22
Metadata
- Authors
- Yoon, S. P., Grewal, D. S., Thompson, A. C., Polascik, B. W., Dunn, C., Burke, J. R., & Fekrat, S.
- Venue
- Ophthalmology Retina
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 3
- Issue
- 6
- Pages
- 489-499
- ISSN
- 2468-6530 (ISSN-L)
- OpenAlex
- W2920900638
- Cited by
- 228
- References
- 7
- FWCI
- 17.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.